Skip to main content

Adicet Bio, Inc.

ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001720580

No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Adicet Bio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
98
+21 vs. Q4 2023
Shares held
75.1M
+41.8M (+125.2%) vs. Q4 2023
Total value
$176.6M
+$113.6M (+180.1%) vs. Q4 2023
New holders
32
40 more added
Sold out
11
13 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACET on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 98 institutions
Q1 2021: 54 institutionsQ2 2021: 66 institutionsQ3 2021: 58 institutionsQ4 2021: 81 institutionsQ1 2022: 88 institutionsQ2 2022: 101 institutionsQ3 2022: 102 institutionsQ4 2022: 100 institutionsQ1 2023: 107 institutionsQ2 2023: 95 institutionsQ3 2023: 84 institutionsQ4 2023: 77 institutionsQ1 2024: 98 institutionsQ2 2024: 86 institutionsQ3 2024: 64 institutionsQ4 2024: 64 institutionsQ1 2025: 56 institutionsQ2 2025: 49 institutionsQ3 2025: 54 institutionsQ4 2025: 49 institutionsQ1 2026: 49 institutionsQ2 2026: 56 institutions
Value heldQ1 2024: $176.6M
Q1 2021: $266.3MQ2 2021: $218.1MQ3 2021: $156.1MQ4 2021: $531.2MQ1 2022: $660.4MQ2 2022: $555.9MQ3 2022: $590.7MQ4 2022: $375.7MQ1 2023: $231.3MQ2 2023: $90.4MQ3 2023: $48.9MQ4 2023: $63.0MQ1 2024: $176.6MQ2 2024: $77.4MQ3 2024: $82.3MQ4 2024: $55.4MQ1 2025: $42.0MQ2 2025: $31.5MQ3 2025: $41.6MQ4 2025: $56.6MQ1 2026: $43.7MQ2 2026: $52.8M
Institutions holding ACET and their total value by quarter
QuarterHoldersValue
Q2 202656$52.8M
Q1 202649$43.7M
Q4 202549$56.6M
Q3 202554$41.6M
Q2 202549$31.5M
Q1 202556$42.0M
Q4 202464$55.4M
Q3 202464$82.3M
Q2 202486$77.4M
Q1 202498$176.6M
Q4 202377$63.0M
Q3 202384$48.9M
Q2 202395$90.4M
Q1 2023107$231.3M
Q4 2022100$375.7M
Q3 2022102$590.7M
Q2 2022101$555.9M
Q1 202288$660.4M
Q4 202181$531.2M
Q3 202158$156.1M
Q2 202166$218.1M
Q1 202154$266.3M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Adicet Bio, Inc.; share changes are against Q4 2023.

Institutions holding ACET in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Gsa Capital Partners LLP0$00.00%−20,674−100.0%Sold out
Summit Trail Advisors, LLC0$00.00%−18,000−100.0%Sold out
Simplex Trading, LLC0$00.00%−16,540−100.0%Sold out
Wexford Capital LP0$00.00%−14,930−100.0%Sold out
Group One Trading, L.P.0$00.00%−5,487−100.0%Sold out
Point72 Middle East FZE0$00.00%−4,623−100.0%Sold out
Federated Hermes, Inc.0$00.00%−3,423−100.0%Sold out
Northwest Financial Advisors0$00.00%−1,685−100.0%Sold out
Glassman Wealth Services0$00.00%−456−100.0%Sold out